Ascend Wellness Holdings (AAWH) Share-based Compensation Growth (1y) (2021 - 2025)
Ascend Wellness Holdings (AAWH) Share-based Compensation Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.85 Bn | 32.11 Bn | 1.97 Bn | 26.47% |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn | 47.06% |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn | 8.79% |
| 5 | United Therapeutics | 23.16 Bn | 21.01 Bn | 648.10 Mn | 281.05% |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.33 Bn | 18.53 Bn | 1.16 Bn | 92.83% |
| 8 | Neurocrine Biosciences | 17.74 Bn | 16.43 Bn | 800.70 Mn | 5.49% |
| 9 | Elanco Animal Health | 12.64 Bn | 12.21 Bn | 785.00 Mn | 61.54% |
| 10 | Ascend Wellness Holdings | 77.94 Mn | 17.02 Mn | 44.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 89.59% |
| Jun 30, 2025 | -78.44% |
| Dec 31, 2024 | -79.53% |
| Sep 30, 2024 | -178.84% |
| Mar 31, 2024 | 10,616.00% |
| Dec 31, 2023 | 1,920.91% |
| Sep 30, 2023 | 307.48% |
| Dec 31, 2022 | 104.00% |
| Sep 30, 2022 | -181.65% |
| Jun 30, 2022 | 567.63% |
| Dec 31, 2021 | -2,217.70% |
| Sep 30, 2021 | 11,436.62% |
| Jun 30, 2021 | -3,025.88% |
| Mar 31, 2021 | 1,244.32% |